C4 Therapeutics - Stock Price History | CCCC

Historical daily share price chart and data for C4 Therapeutics since 2021 adjusted for splits. The latest closing stock price for C4 Therapeutics as of September 24, 2021 is 49.16.
  • The all-time high C4 Therapeutics stock closing price was 50.50 on September 23, 2021.
  • The C4 Therapeutics 52-week high stock price is 51.21, which is 4.2% above the current share price.
  • The C4 Therapeutics 52-week low stock price is 22.40, which is 54.4% below the current share price.
  • The average C4 Therapeutics stock price for the last 52 weeks is 36.67.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
C4 Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 28.9990 25.4900 37.0500 22.8000 33.1300 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.447B $0.033B
C4 Therapeutics Inc. is a biopharmaceutical company. It is focused on harnessing the body's natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases. C4 Therapeutics Inc. is based in WATERTOWN, Mass.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71